Phase 4 Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been admitted to an intensive care unit (ICU) and are receiving breathing support through a mask or high-flow oxygen, or are on a breathing machine, where that support is expected to last more than 24 hours due to breathing difficulties
- People in the ICU who are receiving medications to support their blood pressure or heart function, where that support is expected to last more than 24 hours
- People who have been admitted to the ICU following a cardiac arrest (when the heart stops beating)
- People who are having their heart rhythm continuously monitored
Who may not be able to join:
- People who have already been receiving ICU breathing or heart support treatments for more than 18 hours before enrolling
- People who are on a breathing machine solely to keep their airway safe, such as after a head injury, rather than for breathing failure
- People who have an irregular heart rhythm called atrial fibrillation at the time of enrolment
- People who are currently taking a heart medication called Amiodarone, either as tablets or through a continuous drip
- People who are not expected to survive more than 24 hours, or who are receiving palliative (comfort-focused) care
- People who have had cardiac (heart) surgery
- People who need magnesium given through a drip or injection for conditions such as pre-eclampsia or asthma
- People who are currently receiving dialysis (a treatment that filters the blood when the kidneys cannot)
- Females under 50 years old who have a positive pregnancy test
- People who have previously been enrolled in this trial
- People whose treating doctor decides enrolment is not appropriate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stephanie Sibley, MD, Queen's University
Phone: 613 549 6666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
RCT Feasibility; RCT Feasibility
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.